• Plasma Protein Therapies

    Uniquely Saving Lives


Plasma-derived therapies and their recombinant analogs, collectively referred to as plasma protein therapies, are unique, biologic medicines, versus synthetic or chemical medicines, because production begins with plasma, a biologic starting material. These unique therapies replace missing or deficient proteins found in plasma, allowing their recipients to lead healthier and more productive lives.

The patient populations that rely on plasma protein therapies generally require regular infusions or injections for the duration of their lives. Plasma protein therapies are not interchangeable and have been defined by regulators as sole-source biologic products because no generics or substitutions exist.


Each plasma donation center employs between 50 - 100 people.

Local Economies

Source plasma donation centers provide an economic impact of more than $4 million to the communities where they are located.

Strength in Numbers

In 2019, there were more than 53 million plasma donations in the U.S.

Repeat Engagement

The average donor donates 21 times per year.

1,100 and Counting!

There are more than 1,100 plasma donation centers in the United States.

Copyright © 2023 PPTA | Privacy Statement